跳至主要内容
临床试验/NCT02334839
NCT02334839Unknown不适用

The Association Between Severity of Hypertensive Disorder During Pregnancy and Endothelial Dysfunction

Rabin Medical Center1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
150
试验地点
1
主要终点
Reactive Hyperemia Index (RHI)

研究概览

简要总结

Preeclampsia toxemia (PET) is a pregnancy related complication that is usually expressed as new onset hypertension and proteinuria after 20 weeks of gestation. scarce data exists regarding the effectiveness of PAT plethysmography use in women with PET and whether adverse results are found compared to healthy gravidas. Thus, we aimed to assess endothelial function using PAT plethysmography in women with PET and compare their results to both healthy gravidas and those with only gestational hypertension.

.

详细描述

Preeclampsia toxemia (PET) is a pregnancy related complication that is usually expressed as new onset hypertension and proteinuria after 20 weeks of gestation. Although the exact pathophysiology is unclear, it's related to abnormal placentation and subsequent vascular pathology. Endothelial dysfunction was found to play a significant role in the risk of cardiovascular event in general. Moreover, few studies found a relation between endothelial dysfunction and PET. There are several methods for the assessment of endothelial function, with Peripheral Artery Tone (PAT) plethysmography being an emerging non-invasive promising technique. However, scarce data exists regarding the effectiveness of PAT plethysmography use in women with PET and whether adverse results are found compared to healthy gravidas.

Thus, we aimed to assess endothelial function using PAT plethysmography in women with PET and compare their results to both healthy gravidas and those with only gestational hypertension.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Maternal age 18-40 years old
  • 27 and above weeks of gestation
  • Singleton pregnancy
  • Agreed to participate in the study and signed on informed consent form.

排除标准

  • Known ischemic heart disease or angina pectoris
  • Active smoker
  • Dyslipidemia, chronic hypertension. Renal disease, diabetes mellitus (gestational or pregestational)
  • Active treatment with anti-hypertensive medication, anti-aggregation medication or lipid lowering agents.

结局指标

主要结局

Reactive Hyperemia Index (RHI)

时间窗: 24 months

The difference in Reactive Hyperemia Index (RHI) as messureas using the ENDOPAT device between the study groups

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Liran hiersch

MD

Rabin Medical Center

研究点 (1)

Loading locations...

相似试验

The Association Between Severity of Hypertensive... | 临床试验